In a complete response letter published by the FDA on Monday, the agency said a resubmission for REGENXBIO’s Hunter syndrome gene therapy should provide evidence of normalized or improved biomarker ...

In a strikingly blunt briefing, a senior FDA official accused uniQure of pushing “distorted” data to mask a “failed” therapy ...

Going out of your comfort zone is scary. That said, the awkward yet empowering practice of becoming extroverted is something to consider! Let's talk about it.

UniQure and REGENXBIO are both dealing with FDA setbacks for their respective gene therapies, as regulatory experts question ...

Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. | Disc Medicine is laying off a fifth of its workforce as the ...

When you grow up without close friends, you end up spending a lot of time inside your own head. You learn how to observe people instead of blending into them. You figure out how to entertain yourself.

Acadia Pharmaceuticals isn’t taking its recent rejection from the European Medicines Agency lying down, vowing to seek a ...

At a recent career fair, students said they had submitted dozens or hundreds of applications. One tried "AI-proofing" his ...

Research using the Adult Attachment Interview suggests that individuals with earned secure attachment are not defined by ...

Emotions may reflect the brain’s predictions, not just reactions. Change happens when we stay with an experience long enough ...

The question worth asking isn't why a baby monkey is so adorable. It's why so many of us saw our own stories in his.

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial results for fourth quarter and full year 2025 and provided ...